Metabolix Targets Integrated Chemical Production

Less than three months after Archer Daniels Midland’s (ADM) exit from bioplastics joint venture Telles left an uncertain future for partner Metabolix (Cambridge, MA) and its biobased polyhydroxyalkanoate (PHA) technology, Metabolix CEO Rick Eno tells CW the company will soon relaunch with a more profitable business model, smaller-scale manufacturing facility, and an expanded product slate integrating biopolymers and biobased chemicals. Renewable Revamp: PHA outlook remains bright. ADM’s exit left Metabolix in a bind. The agribusiness giant retained...

This information is only available to Chemical Week subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not an IHS Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive access of the last 2 years of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers